BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16216357)

  • 1. Hematopoietic stem cell gene therapy: dead or alive?
    Ferguson C; Larochelle A; Dunbar CE
    Trends Biotechnol; 2005 Dec; 23(12):589-97. PubMed ID: 16216357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards hematopoietic stem cell gene therapy.
    Kurre P; Kiem HP
    Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.
    Gaspar HB; Howe S; Thrasher AJ
    Gene Ther; 2003 Nov; 10(24):1999-2004. PubMed ID: 14566358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of severe combined immunodeficiencies.
    Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
    J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.
    Papapetrou EP; Zoumbos NC; Athanassiadou A
    Gene Ther; 2005 Oct; 12 Suppl 1():S118-30. PubMed ID: 16231044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling human hematopoietic stem cell gene therapy in nonhuman primates.
    Hematti P
    Curr Hematol Rep; 2004 Jul; 3(4):282-9. PubMed ID: 15217558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell gene therapy: progress toward therapeutic targets.
    Vollweiler JL; Zielske SP; Reese JS; Gerson SL
    Bone Marrow Transplant; 2003 Jul; 32(1):1-7. PubMed ID: 12815471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of gene therapy for haematological disorders.
    Nathwani AC; Davidoff AM; Linch DC
    Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine. Gene therapy--new challenges ahead.
    Williams DA; Baum C
    Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
    Mikkers H; Pike-Overzet K; Staal FJ
    Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal stem-cell and gene therapy for hemoglobinopathies.
    Surbek D; Schoeberlein A; Wagner A
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):282-90. PubMed ID: 18420474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for childhood immunological diseases.
    Kohn DB
    Bone Marrow Transplant; 2008 Jan; 41(2):199-205. PubMed ID: 17994122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal gene therapy: opportunities and risks.
    Wagner AM; Schoeberlein A; Surbek D
    Adv Drug Deliv Rev; 2009 Aug; 61(10):813-21. PubMed ID: 19426772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for inherited immunodeficiencies.
    Howe S; Thrasher AJ
    Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successes and risks of gene therapy in primary immunodeficiencies.
    Chinen J; Puck JM
    J Allergy Clin Immunol; 2004 Apr; 113(4):595-603; quiz 604. PubMed ID: 15100660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.